Literature DB >> 2727051

Profile of drug-metabolizing enzymes in human ileum and colon.

G M Pacifici1, M Franchi, P G Gervasi, V Longo, P di Simplicio, A Temellini, L Giuliani.   

Abstract

Six patients (4 women and 2 men, age between 60 and 90 years), subjected to right hemicolectomy, were gut donors. The mucosa was isolated from the last portion of the ileum and the first portion of the colon. Tissue specimens were free from pathological changes. The activities of the enzymes of phase I (NADPH cytochrome c reductase, ethoxycoumarin O-deethylase, aminopyrine N-demethylase, microsomal epoxide hydrolase, cytosolic epoxide hydrolase, glutathione reductase and glutathione peroxidase) and the enzymes of phase II (glutathionetransferase, glucuronyltransferase, acetyltransferase, thioltransferase, sulphotransferase and glyoxalase) were measured in the microsomal or cytosolic fractions obtained from ileum and colon mucosa. The activity in the ileum was higher than in the colon for NADPH cytochrome c reductase (p less than 0.05) and cytosolic epoxide hydrolase (p less than 0.001) (phase I enzymes), and glutathionetransferase (p less than 0.02), sulphotransferase (p less than 0.05) and glyoxalase (p less than 0.02) (phase II enzymes). The other enzymes had similar activities in two mucosa. The distribution pattern of drug metabolizing enzymes cannot be considered as a single pattern in human ileum and colon because of the observed enzyme-dependent differences.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2727051     DOI: 10.1159/000138530

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  6 in total

Review 1.  Human colonocyte detoxification.

Authors:  W E Roediger; W Babidge
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

2.  Distribution of 2-naphthol sulphotransferase and its endogenous substrate adenosine 3'-phosphate 5'-phosphosulphate in human tissues.

Authors:  M Cappiello; M Franchi; L Giuliani; G M Pacifici
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  First-pass metabolism of diltiazem in anesthetized rabbits: role of extrahepatic organs.

Authors:  M Lefebvre; W Homsy; G Caillé; P du Souich
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

Review 4.  Extrahepatic metabolism of drugs in humans.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

5.  The site of absorption in the small intestine determines diltiazem bioavailability in the rabbit.

Authors:  W Homsy; G Caillé; P du Souich
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

6.  Sulfur metabolism in ulcerative colitis: investigation of detoxification enzymes in peripheral blood.

Authors:  M C Pitcher; E R Beatty; R M Harris; R H Waring; J H Cummings
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.